Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Common Equity came in at $51.4 million in Q1 2026, up 154.84% year-on-year from $20.2 million in Q1 2025, and up 125.36% on a QoQ basis from $22.8 million in Q4 2025.

Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Common Equity data on file, last reported at $51.4 million in Q1 2026.

  • On a quarterly basis, Common Equity rose 154.84% year-over-year to $51.4 million in Q1 2026; TTM through Mar 2026 was $51.4 million, a 154.84% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, down 20.93% from the prior year.
  • Common Equity for Q1 2026 stood at $51.4 million, up from $22.8 million in the prior quarter.
  • Over the last five years, Common Equity for SLGL reached as high as $51.4 million in Q1 2026 and fell as low as $20.2 million in Q1 2025.
  • Historically, Common Equity has averaged $38.1 million across 5 years, with a median of $38.6 million in 2023.
  • Across the five-year window, Common Equity slumped 38.22% in 2025 and soared 154.84% in 2026, its largest moves.
  • Year by year, Common Equity stood at $42.2 million in 2022, then dropped by 8.45% to $38.6 million in 2023, then dropped by 25.34% to $28.8 million in 2024, then declined by 20.93% to $22.8 million in 2025, then jumped by 125.36% to $51.4 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $51.4 million in Q1 2026, $22.8 million in Q4 2025, and $26.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 51.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.41 Mn
Dec 31, 2025 22.81 Mn
Sep 30, 2025 26.03 Mn
Jun 30, 2025 31.88 Mn
Mar 31, 2025 20.17 Mn
Dec 31, 2024 28.85 Mn
Sep 30, 2024 34.71 Mn
Jun 30, 2024 34.90 Mn
Mar 31, 2024 32.65 Mn
Dec 31, 2023 38.64 Mn
Sep 30, 2023 43.13 Mn
Jun 30, 2023 48.30 Mn
Mar 31, 2023 44.06 Mn
Dec 31, 2022 42.21 Mn
Sep 30, 2022 47.47 Mn
Jun 30, 2022 50.35 Mn
Mar 31, 2022 50.12 Mn
Dec 31, 2021 55.59 Mn
Sep 30, 2021 41.44 Mn
Jun 30, 2021 39.25 Mn